Brookdale Senior Living (BKD) is stepping into the spotlight with back to back appearances at the Jefferies Healthcare Services and Technology Conference and the BofA NY Global Real Estate Conference this September.
Recent trading has been choppy for Brookdale Senior Living, with the share price down about 16% over the past 90 days. Even though the year to date share price return is positive and the 1 year and 3 year total shareholder returns of 44.75% and 168.15% point to strong underlying momentum, the upcoming conferences may help investors reassess.
Compare Brookdale Senior Living's recent swings with hand picked operators and healthcare peers showing strong fundamentals in the list of solid balance sheet and fundamentals (23 results) .
For Brookdale Senior Living, a 16% pullback over 90 days sits against powerful multi year gains and stronger earnings expectations. Is this related to the underlying business, or is sentiment simply resetting the price investors are willing to pay today?
Most Popular Narrative: 33% Undervalued
On the most widely followed narrative, Brookdale Senior Living screens at a fair value of $17.00 compared with a last close of $11.45, which puts the current pullback against a much higher long run anchor in that framework.
Brookdale's accelerating occupancy rates, now consistently above the critical 80 percent threshold, have led to robust free cash flow generation and rising adjusted EBITDA, signaling that core revenue and earnings power are on an improving long-term trajectory. The company has demonstrated effective portfolio optimization by shedding underperforming assets and focusing on high-potential communities, which is expected to increase occupancy rates, revenue per occupied room, adjusted EBITDA, and overall net margins over time.
See why 1 investors see Brookdale Senior Living as 33% undervalued .
Result: Fair Value of $17.00 (UNDERVALUED)
Still, Brookdale Senior Living faces pressure from higher labor costs and potential regulatory changes that could reduce margins and challenge the current fair value story.
Find out about the key risks to this Brookdale Senior Living narrative .
Another View: Brookdale Senior Living On Sales Based Pricing
There is a catch in the Brookdale Senior Living story. On a P/S of 0.9x, the stock trades below both the US Healthcare sector at 1.3x and a peer average of 1.4x, yet slightly above a fair ratio of 0.8x that our model suggests the market could drift toward over time.
This gap points to a mix of potential upside and downside. If sentiment weakens, the price could compress toward that lower fair ratio, while any improvement in the business might justify the current premium to it. Which side of that trade off feels more realistic to you right now?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Sentiment on Brookdale Senior Living is clearly split, with both optimism and caution in the mix. Check the numbers yourself and consider acting before views settle. To weigh both sides in one place, review the 2 key rewards and 1 important warning sign
Looking for more Brookdale Senior Living sized ideas?
If Brookdale Senior Living has your attention, do not stop there. Use curated screeners to surface other opportunities before they move beyond attractive territory.
-
Target value plays that pair quality with reasonable pricing through the 33 high quality undervalued stocks .
-
Prioritize resilience and capital preservation by scanning companies in the 30 resilient stocks with low risk scores .
-
Get ahead of the crowd by reviewing financially solid operators with the 16 high quality undiscovered gems .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BKD .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
